GlassScriptPhysician profile
Emily Mccollum
NPI 1225741960
$2,084.44
in general payments reported to CMS, 2019-2025
15 companies · $999 in 2025
The $999 reported for 2025 was more than what 85% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.53 · 2023: $581 · 2024: $491 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,070.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $885.17 | 2022-2025 | Lifevest |
| Abiomed | $528.27 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $189.66 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.45 | 2023-2024 | Jardiance |
| Boston Scientific Corporation | $59.12 | 2025 | Watchman Access System |
| Janssen Pharmaceuticals, INC | $55.02 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $52.70 | 2023-2024 | Verquvo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $44.90 | 2025 | Caplyta |
| Sanofi-Aventis U.S. LLC | $35.53 | 2023 | |
| Pfizer INC. | $34.01 | 2023-2024 | |
| Cvrx, INC. | $30.59 | 2023 | Barostim Neo System |
| Daiichi Sankyo INC. | $28.81 | 2023 | Injectafer |
| Astrazeneca Pharmaceuticals LP | $19.32 | 2023 | Brilinta |
| Amgen INC. | $19.16 | 2024 | Repatha |
| Inspire Medical Systems, INC. | $15.73 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Mccollum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.